Denali Therapeutics Appoints Alexander Schuth as Chief Operating and Financial Officer as Steve Krognes Transitions to Denali Board of Directors

SOUTH SAN FRANCISCO, Calif., March 15, 2022 -- Denali Therapeutics Inc. , a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood-brain... | March 15, 2022

Related Keywords

Germany ,Berlin ,London ,City Of ,United Kingdom ,Roche Genentech ,Steve Krognes ,Vicki Sato ,Lizzie Hyland ,Morgan Warners ,Ryan Watts ,Alexander Schuth ,Laura Hansen ,Denali Therapeutics Inc ,Merrill Lynch ,Genentech ,Humboldt University ,Charite Medical School ,Board Of Directors Corvus Pharmaceuticals ,Nasdaq ,Harvard Business School ,Wharton School Of The University Pennsylvania ,Chief Financial Officer ,Chief Operating Officer Alexander Schuth ,Chief Operating ,Chief Executive ,Chief Financial ,Denali Therapeutics ,Chief Operating Officer ,Financial Officer ,Wharton School ,Gritstone Bio ,Corvus Pharmaceuticals ,South San ,Denali Therapeutics Inc Stock Exchange ,News ,Information ,Press Release ,Mouth ,Han ,Arch ,022 ,Denali ,Herapeutics ,Iopharmaceutical ,Company ,Developing ,Road ,Portfolio ,F ,Product ,Candidates ,Engineered ,O ,Cross ,He Dnli Us24823r1059 ,